Nordic Bioscience

About:

Nordic Bioscience is dedicated to preclinical and clinical drug development, specializing in personalized medicine using unique biomarker.

Website: http://www.nordicbioscience.com/

Top Investors: Kohlberg Kravis Roberts

Description:

Nordic Bioscience is a biotech firm that studies extracellular matrix (ECM). It uses Protein Fingerprint technology to identify ECM fragments released from affected tissues and to develop blood-based biomarker assays to quantify disease activity in the pursuit of precision medicine. Nordic Bioscience is based in Herlev, Denmark, and operates a high-quality standard laboratory that conducts clinical trials in accordance with Good Clinical Laboratory Practice (GCLP) and is accredited by the College of American Pathologists (CAP), and has an ISO9001 certificate.

Total Funding Amount:

$100M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Herlev, Hovedstaden, Denmark

Founded Date:

1991-01-01

Contact Email:

info(AT)nordicbioscience.com

Founders:

Bente Christiansen, Claus Christiansen

Number of Employees:

51-100

Last Funding Date:

2021-03-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai